Tuesday, February 5, 2019

control of inflammation

It is interesting to note in this study that 22 (81%) of the 27 patients with anti-CCP developed RA during this period. After one year 51 patients (46% of the total) had developed RA. It is interesting to note in this study that 22 (81%) of the 27 patients with anti-CCP developed RA during this period.

The goal of RA therapy is the rigorous control of inflammation so that by stopping the progression of the disease, joint erosion can be prevented and subsequent disability ensue. For this Flekosteel, it is necessary to establish an early diagnosis in the course of RA, identify the patients most likely to follow a rapidly progressive form and initiate a more intense therapy in these patients with a poor prognosis.

No comments:

Post a Comment